FDA 483 - Belcher Pharmaceuticals, LLC - November 04, 2022

Belcher Pharmaceuticals, LLC in Largo, FL, was inspected by the FDA, resulting in two observations related to inadequate laboratory controls and insufficient investigation records. The firm failed to prevent potential contamination of drug product ingredients and did not adequately investigate out-of-specification results, raising concerns about product quality and data reliability.